TreeWAS – Variant ID: rs3812497

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	1.000	0.000	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	1.000	0.000	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.998	0.002	0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.997	0.003	0.000
T43.2 Other and unspecified antidepressants	0.994	0.006	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.993	0.007	0.000
D12.2 Ascending colon	0.992	0.008	0.000
D12.5 Sigmoid colon	0.989	0.011	0.000
D12.4 Descending colon	0.989	0.011	0.000
D12.6 Colon, unspecified	0.975	0.025	0.000
D12.8 Rectum	0.970	0.030	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.969	0.031	0.000
T39.0 Salicylates	0.962	0.038	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.941	0.059	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.938	0.062	0.000
D12.7 Rectosigmoid junction	0.922	0.078	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.915	0.085	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.888	0.112	0.000
T43.6 Psychostimulants with abuse potential	0.887	0.113	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.859	0.141	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.854	0.146	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.847	0.153	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.846	0.154	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.841	0.159	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.833	0.167	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.828	0.172	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.806	0.194	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.801	0.199	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.780	0.220	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.769	0.231	0.000
T39.1 4-Aminophenol derivatives	0.749	0.251	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.731	0.268	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.730	0.270	0.000
T40.4 Other synthetic narcotics	0.727	0.273	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.717	0.283	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.717	0.283	0.000
T43.9 Psychotropic drug, unspecified	0.717	0.283	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.717	0.283	0.000
T39.4 Antirheumatics, not elsewhere classified	0.716	0.284	0.000
T39.2 Pyrazolone derivatives	0.716	0.284	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.710	0.290	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.701	0.299	0.000
T40.6 Other and unspecified narcotics	0.692	0.308	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.687	0.313	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.685	0.315	0.000
T38.1 Thyroid hormones and substitutes	0.682	0.318	0.000
T36 Poisoning by systemic antibiotics	0.679	0.321	0.000
T50.7 Analeptics and opioid receptor antagonists	0.675	0.325	0.000
T50.5 Appetite depressants	0.675	0.325	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.675	0.325	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.675	0.325	0.000
T50.1 Loop [high-ceiling] diuretics	0.675	0.325	0.000
T50.0 Mineralocorticoids and their antagonists	0.675	0.325	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.672	0.328	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.672	0.328	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.672	0.328	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.672	0.328	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.672	0.328	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.672	0.328	0.000
T44.0 Anticholinesterase agents	0.672	0.328	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.660	0.340	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.637	0.363	0.000
T42.3 Barbiturates	0.637	0.363	0.000
T42.2 Succinimides and oxazolidinediones	0.637	0.363	0.000
T45.5 Anticoagulants	0.634	0.366	0.000
T45.2 Vitamins, not elsewhere classified	0.628	0.372	0.000
D12.1 Appendix	0.627	0.372	0.000
T42.0 Hydantoin derivatives	0.624	0.376	0.000
T50.8 Diagnostic agents	0.614	0.386	0.000
T50.4 Drugs affecting uric acid metabolism	0.612	0.388	0.000
T38.9 Other and unspecified hormone antagonists	0.607	0.393	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.607	0.393	0.000
T38.7 Androgens and anabolic congeners	0.607	0.393	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.607	0.393	0.000
T38.5 Other oestrogens and progestogens	0.607	0.393	0.000
T38.4 Oral contraceptives	0.607	0.393	0.000
T38.2 Antithyroid drugs	0.607	0.393	0.000
T38.0 Glucocorticoids and synthetic analogues	0.607	0.393	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.603	0.396	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.602	0.398	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.600	0.400	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.598	0.402	0.000
T45.8 Other primarily systemic and haematological agents	0.598	0.402	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.598	0.402	0.000
T45.6 Fibrinolysis-affecting drugs	0.598	0.402	0.000
T45.4 Iron and its compounds	0.598	0.402	0.000
T45.3 Enzymes, not elsewhere classified	0.598	0.402	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.593	0.406	0.000
T40.8 Lysergide [LSD]	0.593	0.406	0.000
T40.7 Cannabis (derivatives)	0.593	0.406	0.000
T40.5 Cocaine	0.593	0.406	0.000
T40.3 Methadone	0.593	0.406	0.000
T40.1 Heroin	0.593	0.406	0.000
T40.0 Opium	0.593	0.406	0.000
T47.2 Stimulant laxatives	0.584	0.415	0.000
T45.0 Antiallergic and antiemetic drugs	0.577	0.423	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.564	0.435	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.559	0.441	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.559	0.441	0.000
T47.7 Emetics	0.559	0.441	0.000
T47.6 Antidiarrhoeal drugs	0.559	0.441	0.000
T47.5 Digestants	0.559	0.441	0.000
T47.4 Other laxatives	0.559	0.441	0.000
T47.3 Saline and osmotic laxatives	0.559	0.441	0.000
T47.0 Histamine H(2)-receptor antagonists	0.559	0.441	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.551	0.448	0.000
T48.5 Anti-common-cold drugs	0.551	0.448	0.000
T48.4 Expectorants	0.551	0.448	0.000
T48.3 Antitussives	0.551	0.448	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.551	0.448	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.551	0.448	0.000
T48.0 Oxytocic drugs	0.551	0.448	0.000
T41.5 Therapeutic gases	0.514	0.486	0.000
T41.4 Anaesthetic, unspecified	0.514	0.486	0.000
T41.3 Local anaesthetics	0.514	0.486	0.000
T41.2 Other and unspecified general anaesthetics	0.514	0.486	0.000
T41.1 Intravenous anaesthetics	0.514	0.486	0.000
T41.0 Inhaled anaesthetics	0.514	0.486	0.000
T49.9 Topical agent, unspecified	0.514	0.486	0.000
T49.8 Other topical agents	0.514	0.486	0.000
T49.7 Dental drugs, topically applied	0.514	0.486	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.514	0.486	0.000
T49.5 Ophthalmological drugs and preparations	0.514	0.486	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.514	0.486	0.000
T49.3 Emollients, demulcents and protectants	0.514	0.486	0.000
T49.2 Local astringents and local detergents	0.514	0.486	0.000
T49.1 Antipruritics	0.514	0.486	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.514	0.486	0.000
D12.9 Anus and anal canal	0.513	0.487	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.509	0.491	0.000
T37.5 Antiviral drugs	0.509	0.491	0.000
T37.4 Anthelminthics	0.509	0.491	0.000
T37.3 Other antiprotozoal drugs	0.509	0.491	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.509	0.491	0.000
T37.1 Antimycobacterial drugs	0.509	0.491	0.000
T37.0 Sulphonamides	0.509	0.491	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.502	0.498	0.000
T36.3 Macrolides	0.491	0.509	0.000
T36.9 Systemic antibiotic, unspecified	0.486	0.513	0.000
T36.8 Other systemic antibiotics	0.486	0.513	0.000
T36.7 Antifungal antibiotics, systemically used	0.486	0.513	0.000
T36.6 Rifamycins	0.486	0.513	0.000
T36.5 Aminoglycosides	0.486	0.513	0.000
T36.4 Tetracyclines	0.486	0.513	0.000
T36.2 Chloramphenicol group	0.486	0.513	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.486	0.513	0.000
T42.1 Iminostilbenes	0.478	0.522	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.443	0.556	0.000
T36.0 Penicillins	0.443	0.557	0.000
D12.3 Transverse colon	0.442	0.558	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.364	0.636	0.000
D12.0 Caecum	0.359	0.641	0.000
T40.2 Other opioids	0.331	0.669	0.000
T42.4 Benzodiazepines	0.326	0.674	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.320	0.680	0.000
T46.1 Calcium-channel blockers	0.320	0.680	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.318	0.682	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.318	0.682	0.000
T46.7 Peripheral vasodilators	0.318	0.682	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.318	0.682	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.318	0.682	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.291	0.709	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.269	0.731	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.200	0.800	0.001
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.083	0.917	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.082	0.917	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.082	0.918	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.080	0.920	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.079	0.921	0.000
C81 Hodgkin's disease	0.078	0.922	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.077	0.923	0.000
C85.1 B-cell lymphoma, unspecified	0.073	0.927	0.000
C81.9 Hodgkin's disease, unspecified	0.073	0.927	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.073	0.927	0.000
C92 Myeloid leukaemia	0.071	0.929	0.000
C83.1 Small cleaved cell (diffuse)	0.071	0.929	0.000
C83.3 Large cell (diffuse)	0.068	0.932	0.000
C82.0 Small cleaved cell, follicular	0.068	0.932	0.000
C82.4 Follicular lymphoma grade IIIb	0.065	0.935	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.061	0.938	0.000
C81.1 Nodular sclerosis	0.061	0.939	0.000
C92.1 Chronic myeloid leukaemia	0.061	0.939	0.000
C81.2 Mixed cellularity	0.061	0.939	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.059	0.941	0.000
C85.0 Lymphosarcoma	0.059	0.941	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.059	0.941	0.000
C94 Other leukaemias of specified cell type	0.059	0.941	0.000
C88 Malignant immunoproliferative diseases	0.059	0.941	0.000
C86 Other specified types of T/NK-cell lymphoma	0.059	0.941	0.000
C82.6 Cutaneous follicle centre lymphoma	0.057	0.943	0.000
C82.5 Diffuse follicle centre lymphoma	0.057	0.943	0.000
C82.3 Follicular lymphoma grade IIIa	0.057	0.943	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.057	0.943	0.000
C83.6 Undifferentiated (diffuse)	0.057	0.943	0.000
C83.5 Lymphoblastic (diffuse)	0.057	0.943	0.000
C83.4 Immunoblastic (diffuse)	0.057	0.943	0.000
C83.2 Mixed small and large cell (diffuse)	0.057	0.943	0.000
C82.2 Large cell, follicular	0.057	0.943	0.000
C95 Leukaemia of unspecified cell type	0.057	0.943	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.944	0.056
C81.7 Other Hodgkin's disease	0.056	0.944	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.056	0.944	0.000
C81.3 Lymphocytic depletion	0.056	0.944	0.000
C81.0 Lymphocytic predominance	0.056	0.944	0.000
C92.0 Acute myeloid leukaemia	0.056	0.944	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.945	0.055
G31.8 Other specified degenerative diseases of nervous system	0.000	0.945	0.055
G30.9 Alzheimer's disease, unspecified	0.000	0.946	0.054
C92.4 Acute promyelocytic leukaemia	0.054	0.946	0.000
C93 Monocytic leukaemia	0.052	0.947	0.000
C92.9 Myeloid leukaemia, unspecified	0.051	0.949	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.051	0.949	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.051	0.949	0.000
C92.5 Acute myelomonocytic leukaemia	0.051	0.949	0.000
C92.3 Myeloid sarcoma	0.051	0.949	0.000
C92.2 Subacute myeloid leukaemia	0.051	0.949	0.000
G30 Alzheimer's disease	0.000	0.949	0.051
G30-G32 Other degenerative diseases of the nervous system	0.000	0.951	0.049
C83.7 Burkitt's tumour	0.049	0.951	0.000
C92.7 Other myeloid leukaemia	0.049	0.951	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.048	0.952	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.046	0.954	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.045	0.954	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.043	0.957	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.042	0.957	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.042	0.957	0.000
C86.4 Blastic NK-cell lymphoma	0.042	0.957	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.042	0.957	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.042	0.957	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.042	0.957	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.042	0.957	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.042	0.957	0.000
C88.7 Other malignant immunoproliferative diseases	0.042	0.957	0.000
C88.3 Immunoproliferative small intestinal disease	0.042	0.957	0.000
C88.2 Gamma heavy chain disease	0.042	0.957	0.000
C88.1 Alpha heavy chain disease	0.042	0.957	0.000
C94.7 Other specified leukaemias	0.042	0.957	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.042	0.957	0.000
C94.5 Acute myelofibrosis	0.042	0.957	0.000
C94.4 Acute panmyelosis	0.042	0.957	0.000
C94.3 Mast cell leukaemia	0.042	0.957	0.000
C94.2 Acute megakaryoblastic leukaemia	0.042	0.957	0.000
C94.1 Chronic erythraemia	0.042	0.957	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.042	0.957	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.042	0.957	0.000
C96.8 Histiocytic sarcoma	0.042	0.957	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.042	0.957	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.042	0.957	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.042	0.957	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.042	0.957	0.000
C96.3 True histiocytic lymphoma	0.042	0.957	0.000
C96.2 Malignant mast cell tumour	0.042	0.957	0.000
C96.1 Malignant histiocytosis	0.042	0.957	0.000
C96.0 Letterer-Siwe disease	0.042	0.957	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.042	0.958	0.000
C95.7 Other leukaemia of unspecified cell type	0.041	0.959	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.041	0.959	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.000	0.960	0.039
C95.0 Acute leukaemia of unspecified cell type	0.039	0.961	0.000
C95.9 Leukaemia, unspecified	0.039	0.961	0.000
C93.9 Monocytic leukaemia, unspecified	0.038	0.962	0.000
C93.7 Other monocytic leukaemia	0.038	0.962	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.038	0.962	0.000
C93.2 Subacute monocytic leukaemia	0.038	0.962	0.000
C93.0 Acute monocytic leukaemia	0.038	0.962	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.037	0.962	0.000
G30.1 Alzheimer's disease with late onset	0.000	0.963	0.037
G30.0 Alzheimer's disease with early onset	0.000	0.963	0.037
C83.0 Small cell (diffuse)	0.036	0.963	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.036	0.964	0.000
G30.8 Other Alzheimer's disease	0.000	0.964	0.035
C84.8 Cutaneous T-cell lymphoma, unspecified	0.035	0.965	0.000
C84.0 Mycosis fungoides	0.034	0.966	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.000	0.967	0.033
C84.9 Mature T/NK-cell lymphoma, unspecified	0.033	0.967	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.033	0.967	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.033	0.967	0.000
C84.3 Lymphoepithelioid lymphoma	0.033	0.967	0.000
C84.2 T-zone lymphoma	0.033	0.967	0.000
C84.1 Sezary's diease	0.033	0.967	0.000
C93.1 Chronic monocytic leukaemia	0.031	0.969	0.000
G31.0 Circumscribed brain atrophy	0.000	0.970	0.030
C91 Lymphoid leukaemia	0.030	0.970	0.000
C84.4 Peripheral T-cell lymphoma	0.030	0.970	0.000
G31.2 Degeneration of nervous system due to alcohol	0.000	0.974	0.026
C90.1 Plasma cell leukaemia	0.026	0.974	0.000
C90.3 Solitary plasmacytoma	0.025	0.974	0.000
C90.2 Plasmacytoma, extramedullary	0.024	0.976	0.000
C91.4 Hairy-cell leukaemia	0.024	0.976	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.000	0.976	0.024
C91.5 Adult T-cell leukaemia	0.023	0.977	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.022	0.978	0.000
C91.7 Other lymphoid leukaemia	0.022	0.978	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.022	0.978	0.000
C91.3 Prolymphocytic leukaemia	0.022	0.978	0.000
C91.2 Subacute lymphocytic leukaemia	0.022	0.978	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.000	0.979	0.021
F60.9 Personality disorder, unspecified	0.020	0.980	0.000
C91.9 Lymphoid leukaemia, unspecified	0.019	0.981	0.000
R10.2 Pelvic and perineal pain	0.019	0.981	0.000
F60 Specific personality disorders	0.019	0.981	0.000
C84.5 Other and unspecified T-cell lymphomas	0.016	0.983	0.001
F60.3 Emotionally unstable personality disorder	0.017	0.983	0.000
F60.0 Paranoid personality disorder	0.016	0.984	0.000
F60.8 Other specific personality disorders	0.016	0.984	0.000
C91.0 Acute lymphoblastic leukaemia	0.015	0.984	0.000
F60.7 Dependent personality disorder	0.014	0.985	0.000
F60.5 Anankastic personality disorder	0.014	0.986	0.000
F60.4 Histrionic personality disorder	0.014	0.986	0.000
F60.2 Dissocial personality disorder	0.014	0.986	0.000
F60.1 Schizoid personality disorder	0.014	0.986	0.000
K86.1 Other chronic pancreatitis	0.000	0.987	0.013
F60-F69 Disorders of adult personality and behaviour	0.012	0.988	0.000
F60.6 Anxious [avoidant] personality disorder	0.011	0.989	0.000
F69 Unspecified disorder of adult personality and behaviour	0.010	0.989	0.000
F61 Mixed and other personality disorders	0.010	0.990	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.009	0.991	0.000
F68 Other disorders of adult personality and behaviour	0.009	0.991	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.009	0.991	0.000
F65 Disorders of sexual preference	0.009	0.991	0.000
F63 Habit and impulse disorders	0.009	0.991	0.000
C90.0 Multiple myeloma	0.008	0.992	0.000
C91.1 Chronic lymphocytic leukaemia	0.008	0.992	0.000
F64 Gender identity disorders	0.008	0.992	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.000	0.993	0.007
F62.9 Enduring personality change, unspecified	0.007	0.993	0.000
D63.8 Anaemia in other chronic diseases classified elsewhere	0.000	0.993	0.007
F62.8 Other enduring personality changes	0.007	0.993	0.000
F62.1 Enduring personality change after psychiatric illness	0.007	0.993	0.000
F62.0 Enduring personality change after catastrophic experience	0.007	0.993	0.000
D63.0 Anaemia in neoplastic disease	0.000	0.993	0.007
I86.1 Scrotal varices	0.007	0.993	0.000
F63.9 Habit and impulse disorder, unspecified	0.006	0.993	0.000
F63.8 Other habit and impulse disorders	0.006	0.993	0.000
F63.3 Trichotillomania	0.006	0.993	0.000
F63.2 Pathological stealing [kleptomania]	0.006	0.993	0.000
F63.1 Pathological fire-setting [pyromania]	0.006	0.993	0.000
F63.0 Pathological gambling	0.006	0.993	0.000
F65.9 Disorder of sexual preference, unspecified	0.006	0.993	0.000
F65.8 Other disorders of sexual preference	0.006	0.993	0.000
F65.6 Multiple disorders of sexual preference	0.006	0.993	0.000
F65.5 Sadomasochism	0.006	0.993	0.000
F65.4 Paedophilia	0.006	0.993	0.000
F65.3 Voyeurism	0.006	0.993	0.000
F65.2 Exhibitionism	0.006	0.993	0.000
F65.1 Fetishistic transvestism	0.006	0.993	0.000
F65.0 Fetishism	0.006	0.993	0.000
F66.9 Psychosexual development disorder, unspecified	0.006	0.993	0.000
F66.8 Other psychosexual development disorders	0.006	0.993	0.000
F66.2 Sexual relationship disorder	0.006	0.993	0.000
F66.1 Egodystonic sexual orientation	0.006	0.993	0.000
F66.0 Sexual maturation disorder	0.006	0.993	0.000
F68.8 Other specified disorders of adult personality and behaviour	0.006	0.993	0.000
F68.1 Intentional production or feigning of symptoms or disabilities, either physical or psychological [factitious disorder]	0.006	0.993	0.000
F68.0 Elaboration of physical symptoms for psychological reasons	0.006	0.993	0.000
D63 Anaemia in chronic diseases classified elsewhere	0.000	0.994	0.006
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.994	0.006
F64.9 Gender identity disorder, unspecified	0.006	0.994	0.000
F64.8 Other gender identity disorders	0.006	0.994	0.000
F64.2 Gender identity disorder of childhood	0.006	0.994	0.000
F64.1 Dual-role transvestism	0.006	0.994	0.000
K81.0 Acute cholecystitis	0.005	0.995	0.000
K86 Other diseases of pancreas	0.000	0.995	0.005
K86.2 Cyst of pancreas	0.000	0.995	0.005
F64.0 Transsexualism	0.004	0.995	0.000
D63.1 Anaemia in other chronic diseases classified elsewhere	0.000	0.995	0.005
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.995	0.005
K86.3 Pseudocyst of pancreas	0.000	0.995	0.005
C73 Malignant neoplasm of thyroid gland	0.004	0.996	0.000
C44.5 Skin of trunk	0.000	0.996	0.004
O62.2 Other uterine inertia	0.004	0.996	0.000
I86 Varicose veins of other sites	0.004	0.996	0.000
S02.60 Fracture of mandible (closed)	0.000	0.996	0.004
N89.9 Noninflammatory disorder of vagina, unspecified	0.000	0.996	0.004
J44.8 Other specified chronic obstructive pulmonary disease	0.004	0.996	0.000
K63.1 Perforation of intestine (nontraumatic)	0.000	0.996	0.004
N88.2 Stricture and stenosis of cervix uteri	0.000	0.996	0.004
F52.2 Failure of genital response	0.004	0.996	0.000
N88.8 Other specified noninflammatory disorders of cervix uteri	0.000	0.996	0.004
J38.4 Oedema of larynx	0.004	0.996	0.000
I86.8 Varicose veins of other specified sites	0.003	0.996	0.000
I82.9 Embolism and thrombosis of unspecified vein	0.003	0.997	0.000
I74.5 Embolism and thrombosis of iliac artery	0.000	0.997	0.003
N88 Other noninflammatory disorders of cervix uteri	0.000	0.997	0.003
O62 Abnormalities of forces of labour	0.003	0.997	0.000
K60.2 Anal fissure, unspecified	0.000	0.997	0.003
K35.8 Acute appendicitis, other and unspecified	0.000	0.997	0.003
K86.9 Disease of pancreas, unspecified	0.000	0.997	0.003
C74.1 Medulla of adrenal gland	0.003	0.997	0.000
I86.2 Pelvic varices	0.003	0.997	0.000
I86.3 Vulval varices	0.003	0.997	0.000
I86.0 Sublingual varices	0.003	0.997	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.000	0.997	0.003
C74 Malignant neoplasm of adrenal gland	0.003	0.997	0.000
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.003	0.997	0.000
I86.4 Gastric varices	0.003	0.997	0.000
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.003	0.997	0.000
C21.1 Anal canal	0.003	0.997	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.003	0.997	0.000
C26.0 Intestinal tract, part unspecified	0.003	0.997	0.000
O62.3 Precipitate labour	0.003	0.997	0.000
M16.0 Primary coxarthrosis, bilateral	0.000	0.997	0.003
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.997	0.003
E34.0 Carcinoid syndrome	0.003	0.997	0.000
J93.1 Other spontaneous pneumothorax	0.000	0.997	0.003
O62.1 Secondary uterine inertia	0.003	0.997	0.000
C74.9 Adrenal gland, unspecified	0.003	0.997	0.000
K63.9 Disease of intestine, unspecified	0.003	0.997	0.000
D35.0 Adrenal gland	0.003	0.997	0.000
O62.9 Abnormality of forces of labour, unspecified	0.003	0.997	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.003	0.997	0.000
K59.1 Functional diarrhoea	0.000	0.997	0.003
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.003	0.997	0.000
T92.0 Sequelae of open wound of upper limb	0.003	0.997	0.000
D48.1 Connective and other soft tissue	0.000	0.997	0.003
N88.4 Hypertrophic elongation of cervix uteri	0.000	0.997	0.003
N88.1 Old laceration of cervix uteri	0.000	0.997	0.003
N88.0 Leukoplakia of cervix uteri	0.000	0.997	0.003
O62.8 Other abnormalities of forces of labour	0.003	0.997	0.000
O62.0 Primary inadequate contractions	0.003	0.997	0.000
O63.9 Long labour, unspecified	0.003	0.997	0.000
W19.2 School, other institution and public administrative area	0.003	0.997	0.000
I87.2 Venous insufficiency (chronic) (peripheral)	0.003	0.997	0.000
C74.0 Cortex of adrenal gland	0.002	0.997	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.002	0.997	0.000
N88.3 Incompetence of cervix uteri	0.000	0.997	0.002
B96.4 Proteus (mirabilis)(morganii) as the cause of diseases classified to other chapters	0.002	0.998	0.000
E34.9 Endocrine disorder, unspecified	0.002	0.998	0.000
I82 Other venous embolism and thrombosis	0.002	0.998	0.000
E34 Other endocrine disorders	0.002	0.998	0.000
M25.55 Pain in joint (Pelvic region and thigh)	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.7 Excessive sexual drive	0.002	0.998	0.000
F52.6 Nonorganic dyspareunia	0.002	0.998	0.000
F52.5 Nonorganic vaginismus	0.002	0.998	0.000
F52.4 Premature ejaculation	0.002	0.998	0.000
F52.3 Orgasmic dysfunction	0.002	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.002	0.998	0.000
M66.06 Rupture of popliteal cyst-Lower leg	0.002	0.998	0.000
C75.9 Endocrine gland, unspecified	0.002	0.998	0.000
M79.0 Rheumatism, unspecified	0.000	0.998	0.002
M50.2 Other cervical disk displacement	0.002	0.998	0.000
I87 Other disorders of veins	0.002	0.998	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.998	0.002
S60.8 Other superficial injuries of wrist and hand	0.000	0.998	0.002
N89.6 Tight hymenal ring	0.000	0.998	0.002
F52.0 Lack or loss of sexual desire	0.002	0.998	0.000
I82.8 Embolism and thrombosis of other specified veins	0.002	0.998	0.000
M43.1 Spondylolisthesis	0.000	0.998	0.002
C75.8 Pluriglandular involvement, unspecified	0.002	0.998	0.000
C75.5 Aortic body and other paraganglia	0.002	0.998	0.000
C75.4 Carotid body	0.002	0.998	0.000
C75.3 Pineal gland	0.002	0.998	0.000
C75.2 Craniopharyngeal duct	0.002	0.998	0.000
C75.1 Pituitary gland	0.002	0.998	0.000
C75.0 Parathyroid gland	0.002	0.998	0.000
S02.6 Fracture of mandible	0.000	0.998	0.002
H35.5 Hereditary retinal dystrophy	0.002	0.998	0.000
I87.9 Disorder of vein, unspecified	0.002	0.998	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.002	0.998	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.000	0.998	0.002
I82.3 Embolism and thrombosis of renal vein	0.002	0.998	0.000
E34.8 Other specified endocrine disorders	0.002	0.998	0.000
F50.9 Eating disorder, unspecified	0.002	0.998	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.002	0.998	0.000
F50 Eating disorders	0.002	0.998	0.000
D10.3 Other and unspecified parts of mouth	0.002	0.998	0.000
I82.1 Thrombophlebitis migrans	0.002	0.998	0.000
I82.0 Budd-Chiari syndrome	0.002	0.998	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.998	0.002
C21 Malignant neoplasm of anus and anal canal	0.002	0.998	0.000
M43.19 Spondylolisthesis (Site unspecified)	0.000	0.998	0.002
C21.0 Anus, unspecified	0.002	0.998	0.000
F80.1 Expressive language disorder	0.002	0.998	0.000
W19.4 Street and highway	0.002	0.998	0.000
E34.5 Androgen resistance syndrome	0.002	0.998	0.000
E34.4 Constitutional tall stature	0.002	0.998	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.998	0.000
F10.0 Acute intoxication	0.002	0.998	0.000
J38.1 Polyp of vocal cord and larynx	0.002	0.998	0.000
Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.002	0.998	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.000	0.998	0.002
M79.06 Rheumatism, unspecified (Lower leg)	0.000	0.998	0.002
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M79.04 Rheumatism, unspecified (Hand)	0.000	0.998	0.002
M79.03 Rheumatism, unspecified (Forearm)	0.000	0.998	0.002
M79.02 Rheumatism, unspecified (Upper arm)	0.000	0.998	0.002
M79.01 Rheumatism, unspecified (Shoulder region)	0.000	0.998	0.002
I87.1 Compression of vein	0.002	0.998	0.000
I87.0 Postphlebitic syndrome	0.002	0.998	0.000
F51 Nonorganic sleep disorders	0.002	0.998	0.000
G93.3 Postviral fatigue syndrome	0.002	0.998	0.000
T92 Sequelae of injuries of upper limb	0.002	0.998	0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.998	0.002
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.998	0.002
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations